Purple Biotech Ltd
TASE:PPBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shenzhen Transsion Holdings Co Ltd
SSE:688036
|
CN |
|
O
|
Omnitex Industries (India) Ltd
BSE:514324
|
IN |
|
M
|
Minera Valparaiso SA
SGO:MINERA
|
CL |
|
Directel Holdings Ltd
HKEX:8337
|
HK |
|
Aarti Drugs Ltd
NSE:AARTIDRUGS
|
IN |
Purple Biotech Ltd
Other
Purple Biotech Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Purple Biotech Ltd
TASE:PPBT
|
Other
-$1.4m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Other
-$337m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-132%
|
CAGR 10-Years
-7%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Other
-$859k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Other
-$214k
|
CAGR 3-Years
52%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Purple Biotech Ltd
Glance View
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
See Also
What is Purple Biotech Ltd's Other?
Other
-1.4m
USD
Based on the financial report for Sep 30, 2025, Purple Biotech Ltd's Other amounts to -1.4m USD.
What is Purple Biotech Ltd's Other growth rate?
Other CAGR 3Y
-82%
Over the last year, the Other growth was -49%. The average annual Other growth rates for Purple Biotech Ltd have been -82% over the past three years .
